Sigachi is a manufacturer and exporter of pharmaceutical excipients. Our Pharmaceutical Excipients fully meet international standards of quality. These are widely used in many medicines as a carrier of active ingredients in medicines. The products we offer are prepared at the end of our vendor using the best quality ingredient in tandem with industry-laid standards and guidelines.
Sigachi produces excipients of high functionality, including HiCel HFE, HiCel CE15, HiCel SMCC and HiCel 100. These are co-processed products combining MCC with ingredients such as mannitol, guargum, silicon dioxide colloidal, monohydrate lactose and phosphate dicalcium.
Microcrystalline Cellulose & Mannitol: HiCel HFE typically contains 90% MCC and 10% mannitol, but this can be tailored to meet customer requirements. This co-processing enhances the synergistic functionality of the tablet. To ensure product uniformity, the product is also spray-dried
Microcrystalline Cellulose & Guargum : HiCelCE15 co-processed blend has increased palatability. It reduces friability and creates a softer tablet with enhanced compressibility
Microcrystalline Cellulose & Colloidal Silicon dioxide : HiCel SMCC is made up of 98% MCC and 2% silicon dioxide colloidal. This combination optimizes the properties of compaction and flow, allowing high stability and dust-free handling. Wet granulation is also more resistant and insoluble in water.
Microcrystalline Cellulose & Lactose Monohydrate : The HiCel 100 is a co-processed product with 25% MCC and 75% monohydrate lactose. This product is suitable for compaction mechanisms for brittle fracture and plastic deformation and has high flowability, improved consistency and smooth surface tablets. It is suitable for formulations with low doses requiring uniformity of the active pharmaceutical ingredient (API).